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Abstract
Background: We previously showed that equivalence between two identified zebrafish motoneurons is broken by
interactions with identified muscle fibers that act as an intermediate target for the axons of these motoneurons. Here we
investigate the molecular basis of the signaling interaction between the intermediate target and the motoneurons.
Principal Findings: We provide evidence that Netrin 1a is an intermediate target-derived signal that causes two equivalent
motoneurons to adopt distinct fates. We show that although these two motoneurons express the same Netrin receptors,
their axons respond differently to Netrin 1a encountered at the intermediate target. Furthermore, we demonstrate that
when Netrin 1a is knocked down, more distal intermediate targets that express other Netrins can also function to break
equivalence between these motoneurons.
Significance: Our results suggest a new role for intermediate targets in breaking neuronal equivalence. The data we present
reveal that signals encountered during axon pathfinding can cause equivalent neurons to adopt distinct fates. Such signals
may be key in diversifying a neuronal population and leading to correct circuit formation.
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Introduction
Developmentally equivalent cells adopt distinct fates in
response to signals from within an equivalence group or from
neighboring cells [1,2]. The interactions that enable equivalent
neurons to develop cell-specific axon trajectories are generally
thought to occur early [3]. However, early interactions are
unlikely to allow developmentally equivalent neurons to extend
axons to a common target and then form distinct synaptic fields
within that target [4]. This raises the possibility that signals
encountered later in development may contribute to the
formation of local circuits by breaking equivalence between
neurons, thus diversifying the neuronal population [4]. Here we
investigate the molecular identity of a signal encountered during
axon pathway navigation that breaks equivalence between two
motoneurons.
The molecular mechanisms by which developmentally equiva-
lent neurons adopt distinct fates are not entirely clear. Neuronal
equivalence has been defined by cellular studies showing that two
neurons have the potential to develop a particular identity, but
that interactions determine which cell realizes that potential by
adopting a so-called preferred fate [5]. The other cell is then
forced to adopt a non-preferred fate. In some cases the interactions
may occur directly between the equivalent cells, suggesting that a
single signal is sufficient. In other cases the interactions require not
only the two equivalent cells, but also another cell type, suggesting
that breaking neuronal equivalence in these cases involves at least
two distinct signals [6].
Zebrafish embryos possess two initially equivalent spinal
motoneurons that later adopt distinct fates (Figure 1A) [7]. One
of these motoneurons, CaP, is present in all spinal hemisegments
and extends a long axon that innervates ventral muscle [8]. The
other motoneuron, VaP, is present in only about half of the spinal
hemisegments, extends a short axon, and typically dies during
embryonic development [7,9]. CaP and VaP are initially
indistinguishable by morphological and molecular criteria. Their
axons extend out of the spinal cord directly to an intermediate
target, the muscle pioneers (Figure 1A). The muscle pioneers are a
small set of identified muscle fibers that define the horizontal
myoseptum separating dorsal and ventral myotome [10]. Both the
CaP and VaP axons pause at this intermediate target. They then
exhibit different behaviors that reveal that the cells have adopted
distinct fates [6,7]. One cell extends an axon beyond the muscle
pioneers and this cell becomes CaP. In contrast, the axon of the
other cell remains at the muscle pioneers and this cell becomes
VaP [6,7]. Despite these behavioral and morphological differenc-
es, to date no molecular markers that distinguish CaP and VaP at
any stage of their development have been described. Here we refer
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indistinguishable, and as ‘‘CaP and VaP pair’’ at later stages when
they are morphologically distinct.
The cellular interactions that determine which CaP/VaP will
become VaP are complex. A VaP develops only in a spinal
hemisegment in which a CaP is also present; when there is only a
single cell, it always develops as CaP [9]. However, this single cell
has the potential to develop as VaP if it is transplanted next to a
developing CaP [7]. When there are two CaP/VaPs, ablation of
one cell of the pair before axogenesis causes the remaining cell to
develop as CaP [7]. Ablation of CaP at later stages, after its axon
has extended beyond the muscle pioneers, allows the adjacent
VaP to develop into CaP [7]. In constrast, ablation of VaP has no
effect on the adjacent CaP [2,6]. Thus, CaP is the preferred fate
of both CaP/VaPs. In addition, CaP must be present for the
adjacent cell to adopt the VaP fate [6]. The muscle pioneers are
also necessary for a CaP/VaP to adopt the VaP fate [6]. In the
absence of the muscle pioneers, axons of both CaP/VaPs extend
beyond the horizontal myoseptum intermediate target and the
potential VaP essentially develops as a second CaP. Collectively,
these data suggest that both muscle pioneer-derived and CaP-
derived signals are necessary for VaP specification [6]. The
molecular identities and timing of these two signals have yet to be
determined.
In this paper we test the hypothesis that Netrin 1a (Ntn1a) is the
muscle pioneer-derived signal that breaks equivalence between
CaP and VaP. Netrins are a family of secreted proteins that can
attract or repel axons (reviewed by [11]). Netrins also function in
other capacities, including synaptogenesis, cell migration, cell
survival, and tissue morphogenesis (reviewed by [12,13,14]).
Netrins act through several receptors that can function indepen-
dently or together, and thus mediate different Netrin responses by
the same cell [14,15]. Zebrafish ntn1a is expressed by the muscle
pioneers (Figure 1A) around the time of CaP/VaP axon contact
[16], making muscle pioneer-derived Ntn1a an excellent candidate
for promoting VaP cell fate. Cell fate specification is not a function
normally ascribed to axon pathfinding intermediate targets, thus it
could represent an unrecognized mechanism involved in estab-
lishing neuronal circuitry.
Results
Netrin 1a is a muscle pioneer-derived signal necessary for
VaP fate
We predicted that Ntn1a prevents one of the CaP/VaP axons
from extending beyond the muscle pioneers, forcing that cell to
acquire the VaP cell fate. To test this hypothesis, we knocked
down Ntn1a function with a previously published splice-blocking
(SB) morpholino antisense oligonucleotide (MO; Table 1). Similar
to previously reported results [17] we did not observe changes in
muscle pioneers in ntn1a SBMO-injected embryos (Figure 1B–D).
To observe whether CaP and VaP were altered after knocking
down Ntn1a we labeled individual CaPs and VaPs within the same
hemisegment with different fluorescent dyes and followed their
development (Figure 2; Figure 3). In both standard control MO-
injected embryos and ntn1a 5-mispair control MO-injected
embryos (Table 1), VaP and CaP developed normally. Thus,
VaP axons remained stalled at the muscle pioneers in nearly every
case and CaP axons extended to ventral muscle (Figure 2A;
Figure 3). In ntn1a MO-injected embryos, both CaP and VaP
axons extended out of the spinal cord along their normal path to
the muscle pioneers (Figure 2B-B’’), suggesting that as in other
species [18,19,20,21], zebrafish Ntn1a is not required for
ventrally-projecting motor axons to exit the spinal cord. We
followed development of five CaP and VaP pairs in ntn1a MO-
injected embryos (Figure 2B; Figure 3). In these experiments, as in
the controls, all labeled CaPs extended normal axons. In contrast,
VaPs developed abnormally following Ntn1a knockdown. Instead
of having axons that stalled at the muscle pioneers, as in the
controls, all labeled VaPs in ntn1a MO-injected embryos had
axons that extended beyond the muscle pioneers (Figure 2B).
These results are consistent with our hypothesis that Ntn1a is a
muscle pioneer-derived signal that breaks the equivalence between
CaP and VaP by preventing one CaP/VaP axon from extending
beyond the muscle pioneer intermediate target.
Surprisingly, our time-lapse observations showed that following
Ntn1a knockdown, CaP or VaP identity can be plastic and change
over time. For example, in the pair of cells shown in Figure 2B, at
25 hours postfertilization (hpf), the axon of the green cell was
stalled at the horizontal myoseptum, defining it as VaP, and the
axon of the red cell extended into ventral muscle, defining it as
CaP (Figure 2B’). However, by 6 hours later, the CaP axon had
retracted to the horizontal myoseptum, thus the cell that was
initially CaP had become VaP. In addition, the VaP axon had
extended into ventral muscle, thus the cell that was initially VaP
became CaP (Figure 2B’’). We observed this dynamic change
between CaP and VaP identity in two of the five labeled CaP and
VaP pairs. Changes in CaP and VaP identity were not seen in
time-lapse observations of many labeled CaP and VaPs under
normal conditions [6,7], nor in any of the eight labeled CaP and
VaP pairs in standard control or ntn1a 5-mispair MO-injected
embryos. These results are also consistent with our hypothesis that
Ntn1a is a muscle pioneer-derived signal that breaks the
equivalence between CaP and VaP and further suggest that when
this signal is absent or reduced, the identity of these cells remains
labile.
In addition to extending axons beyond the muscle pioneers, at
24 hpf, four of the five labeled VaPs in ntn1a MO-injected
embryos had axons that extended branches along, but not beyond
the horizontal myoseptum (Figure 2B). At 36 hpf, all four labeled
VaPs retained this ectopic branch (Figure 2B). Previous studies
showed that CaPs often extend transient branches in this region
[6,22,23], but such branches have not previously been described
for VaPs. These results suggest that, in addition to breaking the
Figure 1. Ntn1a expressed in the muscle pioneers is a
candidate signal for stopping VaP axon outgrowth.
A. Schematized view of one spinal hemisegment including spinal cord
(sc) and overlying muscle. CaP (red) and VaP (green) axons contact muscle
pioneers (blue) at the first intermediate target. The VaP axon stalls at the
muscle pioneers while the CaP axon continues into ventral myotome (vm).
ntn1a mRNA (yellow) is expressed in muscle pioneers [16] . This image and
following images are oriented laterally with rostral to the left. B–C.
Projected confocal stacks of (B) uninjected and (C) ntn1a SBMO-injected
embryos labeled with F59, a slow muscle fiber marker [70]. At 24 hpf,
muscle pioneers (green fibers in the middle of the images) are present in
both control and MO-injected embryos. D. RT-PCR results confirming
uninjected embryos have wildtype ntn1a (450 bp band) that is absent from
embryos injected with 5.6 ng of ntn1a SBMO (star). Multiple samples were
run in this gel. Lanes containing samples unrelated to ntn1a were cropped
from the figure. Scale bar =20mm.
doi:10.1371/journal.pone.0025841.g001
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branching, a function of Ntn-1 that has previously been described
for retinal ganglion cells in mouse [24]. This additional function
may be another manifestation of Ntn1a preventing VaP from
extending an axon beyond the muscle pioneers or may reflect the
involvement of two independent Ntn1a-mediated pathways in
VaP development.
Table 1. MO sequences used to knock down Netrins, Dcc and Dscam and RT primer sequences used to confirm MO efficacy.
MO MO Sequence (59-39) RT-PCR primers (59-39) Reference
ntn1a SBMO ATGATGGACTTACCGACACATTCGT ntn1a pre-mRNA (F1 X R1)
ntn1a mRNA (F1 X R2)
F1: CTTTCGGAGACGAAAACGAG
R1: GTAGGCGCTTTCCAGAGATG
R2: CTTTGCAGTAGTGGCAGTGG
Suli et al. 2007 [17]; Suli 2006 [26]
ntn1a TBMO CGCCTTCCTCAGCCTCTCCTGTGCT n/a n/a
ntn1a 5-mispair MO ATcATGcACTTAgCGACAgATTgGT (lower
case letters are mismatches)
n/a n/a
ntn1b SBMO TAGTTTAGAAATGACTCACCGACAC ntn1b pre-mRNA (F1 X R1)
ntn1b mRNA (F1 X R2)
F1: CCGACATCAAAGTGACCTTC
R1: GAGCCATCCACACTTGTTGA
R2: TGCACGTCGGTGTGATATAG
complementary to ntn1b exon 1/
intron 1–2 boundary
ntn2 SBMO TTTCGTGACTTACGTAAGCACTCGT net2E1F: TCCGGAGTGTGATCGATGTA
net2E3R: CCTTTAGCACAGCGGTTACA
netrin2 SBMO3, Suli et al., 2007 [17]
dcc TBMO GAATATCTCCAGTGACGCAGCCCAT n/a Suli et al., 2006 [26]
dscam SBMO AAAGATCCTGAAATGCTCACCGGCC dscam pre-mRNA (e2F X i2R)
dscam mRNA (e2F X e3R)
e2F: TTCTCAGTGAAGACCTACATTCC
i2R: ATTCTGGGTAAGAGCTGTGA
e3R: AATGCACTTGAAGACCGCTA
complementary to dscam exon2/
intron 2–3 boundary
dscam TBMO CGCTCCTTTCAATCTCCAAACTAAG n/a DS2M, Yimlamai et al., 2005 [25]
standard control TBMO CCTCTTACCTCAGTTACAATTTATA n/a Gene Tools
https://store2.gene-tools.com/
node/7
doi:10.1371/journal.pone.0025841.t001
Figure 2. Ntn1a is necessary to prevent a second CaP/VaP axon
from extending beyond the muscle pioneers. Projected confocal
stacks of living dye-labeled motoneurons in one spinal hemisegment.
A. VaP axon stalled at muscle pioneers (dashed line) at 36 hpf in
standard control-MO injected embryo. B. nt1a SBMO injected embryos
had two CaP/VaP axons that extended beyond the muscle pioneers.
One CaP/VaP cell also extended an ectopic branch (arrow) along the
horizontal myoseptum. B’-B’’. The same cells as shown in B. At 25 hpf
(B’) the red cell was a CaP, but by 31 hpf (B’’) the red cell had retracted
its axon to the muscle pioneers intermediate target and the green cell
had become CaP. Scale bars =9mm in A, B and 20 mm in B’, B’’.
doi:10.1371/journal.pone.0025841.g002
Figure 3. Netrin signaling prevents the VaP axon from
extending into ventral muscle. We observed three categories of
axon phenotypes in MO-injected embryos. In Category I, CaP axons
extend into ventral muscle and VaP axons extend no farther than the
muscle pioneers (1). In Category II, CaP axons extend into ventral
muscle and a CaP-like axon extended beyond the muscle pioneers, but
no farther than the level of the hypochord (2). In Category III, both CaP
and VaP extend axons to the third intermediate target (3), thus both
cells developed as CaPs.
doi:10.1371/journal.pone.0025841.g003
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distinguish CaP and VaP
Because different combinations of Netrin receptors can lead to
different responses to Netrin, we asked whether CaP and VaP
were distinguished by their expression of Netrin receptors. We
analyzed expression of several Netrin receptor genes, including dcc,
dscam, neo1, neo2, and unc5b (see also Materials and Methods), that
mediate either attraction or repulsion to Netrin [12,14]. Of these
genes we found that only dscam and dcc are expressed in
motoneurons. Moreover, dscam (Figure 4A) and dcc (Figure 5A)
are expressed in both CaP and VaP. These results refute the
simple hypothesis that differences in Netrin-receptor gene
expression between CaP and VaP result in the differential
responses of their axons to Ntn1a.
Dcc is a Netrin receptor necessary for VaP fate
Wetested whether Dscam is necessaryfor VaP axons to stop at the
horizontal myoseptum by knocking down Dscam with a previously
published translation blocking (TB) MO [25] and a SBMO
(Figure 4B; Table 1). Embryos injected with dscam MO exhibited a
range of previously described phenotypes associated with defects in
gastrulation that affect mesoderm and neural plate formation (data
not shown; [25]). These early defects precluded using MOs to
investigate whether Dscam is necessary for VaP cell fate.
To test whether Dcc is required for VaP axons to stop at the
horizontal myoseptum, we knocked down Dcc using a previously
validated TBMO [17,26]. We followed five dye-labeled CaP and
VaP pairs in dcc MO-injected embryos (Figure 5B–D; Figure 3). As
for Ntn1a morpholino knockdown, CaP axon extension was not
altered by Dcc morpholino knockdown. In contrast, following Dcc
knockdown, VaPs extended axons beyond the muscle pioneers
(Figure 5B–D). Initially all of the labeled VaP axons paused at the
muscle pioneers in dcc MO-injected embryos (Figure 5B), but at
later stages, the majority of labeled VaP axons had extended
beyond the muscle pioneers (Figure 5D; Figure 3). Thus, following
Dcc knockdown, VaPs failed to adopt their normal fate and
instead extended axons beyond the muscle pioneers. These results
suggest that Dcc mediates the ability of VaP to respond to Ntn1a.
We cannot rule out the possibility that this is due to autonomous
effects of Dcc in both CaP and VaP.
Additional Netrins act as a failsafe mechanism to prevent
VaP from becoming a second CaP
In ntn1a MO-injected embryos and in dcc MO-injected embryos,
VaPs extended axons beyond the muscle pioneers and thus
resembled CaPs. However, these cells differed from normal CaPs
because their axons remained shorter; we refer to cells with
intermediate axon lengths as ‘‘CaP-like’’ (Figure 2B; Figure 5D).
To learn more about what prevented these CaP-like cells from
fully transforming into CaPs, we examined the regions where their
axons stopped.
Following Ntn1a or Dcc knockdown, CaP-like axons did not
progress beyond the level of the hypochord, an embryonic structure
located along the length of the ventral aspect of the notochord
(http://zfin.org/action/anatomy/term-detail?anatomyItem.zdbID
=ZDB-TERM-100331-29) (Figure 6; Figure 3). This region is
adjacent to the second intermediate target where CaP axons
normally pause during extension toward ventral muscle [27]. The
most ventral aspect of the myotome defines a third intermediate
target where CaP axons normally pause during their extension [27].
However, we never saw CaP-like axons progress to the third
intermediate target following knockdown of Ntn1a or Dcc.
All three CaP intermediate target regions express netrin mRNAs.
As described above, the first intermediate target, the muscle
pioneers, expresses ntn1a (Figure 1A; Figure 6B, C; Figure 7A).
The hypochord at the level of the second intermediate target
expresses ntn1b during the time that the CaP axon is navigating
along this region of its pathway (Figure 6B, C; Figure 7A) [28,29].
Ventrolateral myotome cells in the region of the third intermediate
target express netrin 2 (Figure 6B,C; Figure 7B) [28]. The cells
expressing ntn1b and ntn2 are at different mediolateral positions
within the embryo (Figure 6C). The ntn1b-expressing hypochord is
located along the axial midline. In contrast, the ntn2-expressing
cells are located ventrolaterally within the somite.
Because multiple Netrins act in concert during development to
guide the axons of other spinal neuron populations to their targets
[30], we asked whether combinations of Netrins are required for
the CaP axon to leave the spinal cord and whether Netrins
expressed by CaP intermediate targets are necessary for normal
CaP axon extension. To address these questions, we knocked
down the individual Netrins using MOs (Figure 7C) and followed
CaP development over time. We found that CaPs extended
normally following knockdown of each of the Netrins individually
(Figure 8; see also Figure 2 & Figure 9) as well as following
knockdown of pairs of Netrins (Figure 9). Simultaneous injection of
MOs to all three Netrins produced widespread defects and
neuronal cell death (data not shown) that prevented us from
examining motoneuron development in these embryos. Our
morpholino knockdown results suggest that neither individual
Netrins nor pairs of Netrins act to guide CaP axons out of the
spinal cord or to their intermediate targets. However, in the
absence of knowledge of Netrin protein distribution, we cannot
exclude the possibility that Ntn1b and/or Ntn2 function
redundantly to guide CaP axons from afar.
Similar to our results with CaP, our morpholino knockdown
experiments suggested that Ntn1a is unnecessary for VaP axons to
extend out of the spinal cord and to navigate to the first
intermediate target. VaP axons do not encounter the second and
third intermediate targets and thus are unlikely to be affected by
either ntn1b or ntn2 during normal development. To test this
hypothesis, we knocked down Ntn1b and Ntn2 individually. We
used a splice-blocking MO to knock down Ntn1b and followed
seven dye-labeled CaP and VaP pairs. Five of seven labeled VaPs
did not extend axons beyond the muscle pioneers (Figure 9A–C;
Figure 3). We knocked down Ntn2 with a splice-blocking MO and
followed four dye-labeled CaP and VaP pairs. Axons of all four
VaPs stalled at the muscle pioneers (Figure 9D–F; Figure 3). These
results suggest that neither Ntn1b nor Ntn2 alone is necessary for
the VaP axon to stop at the horizontal myoseptum, consistent with
Figure 4. dscam mRNA is expressed in CaPs and VaPs and
wildtype transcripts were knocked down with SBMOs. A. A
projected confocal stack of dscam mRNA (red) and isl2a mRNA (a CaP/
VaP motoneuron marker [41]) expression (green), reveals that at 24 hpf
dscam is expressed in both CaP and VaP (*; CaP and VaP pair to left,
single CaP to right) as well as other cells that are likely motoneurons.
B. RT-PCR results confirming uninjected embryos have wildtype dscam
mRNA (395 bp band) while MO-injected embryos have increased dscam
pre-mRNA (490 bp band). Starred lanes show dscam transcripts are
absent after injecting 8.4 ng of dscam SBMO. Scale bar =20mm.
doi:10.1371/journal.pone.0025841.g004
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during normal development.
Because CaP-like axons stopped at the second intermediate
target following knockdown of ntn1a or dcc, we hypothesized that
ntn1b and/or ntn2 might affect CaP-like axons similarly to the way
ntn1a affects VaP axons. We therefore asked whether, in the
absence of a Netrin signal from the muscle pioneers, Ntn1b and/
or Ntn2 could prevent a second CaP axon from extending toward
more distal intermediate targets, causing the cell to become CaP-
like. To test this hypothesis, we injected embryos either with ntn1a
plus ntn1b MOs or with ntn1a plus ntn2 MOs, followed
development of dye-labeled CaP and VaP pairs, and obtained
the following results for the two different pairs of MO
combinations.
Ntn1a plus Ntn1b knockdown. We followed seven dye-
labeled pairs of CaPs and VaPs in ntn1a plus ntn1b MO-injected
embryos (Figure 9G–I; Figure 3). All seven labeled VaP axons
extended beyond the horizontal myoseptum and stopped at the
second intermediate target, becoming CaP-like. Interestingly,
during outgrowth one of these cells initially extended an axon
beyond the second intermediate target, but then retracted that
axon back to the second intermediate target by 36 hpf.
Ntn1a plus Ntn2 knockdown. We followed twelve dye-
labeled pairs of CaPs and VaPs in ntn1a plus ntn2 MO-injected
embryos (Figure 9J-L; Figure 3). All twelve labeled VaP axons
extended beyond the horizontal myoseptum. Eight of these cells
became CaP-like, with axons that stopped at the second
intermediate target. Four of these cells extended axons that
reached the third intermediate target and in all four cases both
labeled cells resembled normal CaPs.
Figure 5. Dcc is necessary to prevent a second CaP/VaP axon from extending beyond the muscle pioneers. A. Brightfield image of
lateral view of 24 hpf embryo focusing on the spinal cord. dcc mRNA (blue) is co-localized with a motoneuron marker, PARG:GFP (brown; see also
[47]). The left segment shows one CaP (*) expressing dcc. The right segment shows two CaP/VaPs (**) expressing dcc. dcc is also expressed in
additional cells that are likely other motoneurons and neighboring interneurons. B–D. Projected confocal stacks of living dye-labeled motoneurons in
the same dcc TBMO-injected embryo at three developmental stages. Punctate red and green fluorescence within the spinal cord but not in CaP or
VaP in this and other figures represents dye leakage from the labeling procedure. The left segment shows a CaP (red) in a segment lacking VaP; the
right segment shows both CaP (red) and VaP (green). B. At 26 hpf the VaP axon does not extend beyond the level of the muscle pioneers (dashed
line) but CaP axons extend farther. C. By 30 hpf, CaP axons have extended farther ventrally but the VaP axon still remains near the muscle pioneers.
D. By 36 hpf, CaP axons have reached the ventral aspect of the myotome, providing evidence that Dcc is unnecessary for CaP axon extension. The
VaP axon has extended branches beyond and along the muscle pioneers (arrow). Scale bar =20mm.
doi:10.1371/journal.pone.0025841.g005
Figure 6. Netrin mRNAs are expressed at intermediate targets
(blue ellipses) of the CaP axon as it extends ventrally. A.
Schematized view of one spinal hemisegment including spinal cord (sc)
and overlying muscle. CaP (red) and VaP (green) axons contact muscle
pioneers (blue) at the first intermediate target (1). Later the CaP axon
contacts the second intermediate target (2) at the level of the
hypochord (hc), immediately below the notochord (nc) and extends
farther ventrally to a third intermediate target (3) in ventral myotome
(vm). B. Schematized view detailing expression of ntn1a mRNA (yellow)
in the muscle pioneers, ntn1b mRNA (light blue) near the hypochord,
and ntn2 mRNA (purple) in ventral myotome. C. Schematized view of a
transverse section through an embryonic zebrafish trunk showing CaP
and VaP cell bodies in the spinal cord, intermediate targets of their
ventrally-projecting axons, and expression of netrin mRNAs in
intermediate targets.
doi:10.1371/journal.pone.0025841.g006
Figure 7. Netrin mRNAs are expressed in intermediate targets
of the CaP axon and wildtype transcripts were knocked down
with SBMOs. A. Projected confocal stack of ntn1a and ntn1b mRNA
expression in zebrafish trunk at 24 hpf; ntn1a is expressed in spinal cord
(purple) and muscle pioneers (purple and *). ntn1a staining was false
colored purple. ntn1b mRNA (green) is expressed in floor plate (white
dots) and hypochord, located ventrally to the notochord. B. Brightfield
image of lateral surface of zebrafish trunk at 24 hpf reveals ntn2 is
expressed in ventral somite (white arrowheads). Asterisks denote
muscle pioneers, cells that do not express ntn2. C. RT-PCR results
confirming uninjected embryos have wildtype ntn1b (500 bp band) and
ntn2 (300 bp band) transcript. Starred lanes show netrin transcripts are
reduced or absent after injecting 10.0 ng of ntn1b SBMO or 5.0 ng of
ntn2 SBMO. Multiple samples were run in the gels for ntn1b and ntn2.
Lanes containing samples unrelated to the netrins were cropped from
the figure. Scale bar =20mm.
doi:10.1371/journal.pone.0025841.g007
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intermediate target breaks the equivalence between CaP and VaP
by preventing one of the CaP/VaP axons from extending farther
ventrally. The VaP axon does not normally encounter the
subsequent intermediate targets. Our results demonstrate that
under experimental conditions that allow both CaP/VaP axons to
extend beyond the first intermediate target, one of the axons is
prevented from extending farther by a Netrin signal from a
subsequent intermediate target. Together these results suggest that
the same set of signaling interactions can occur at multiple
locations, providing a failsafe mechanism for preventing formation
of a second CaP, and revealing a new role for intermediate targets
in breaking neuronal equivalence.
Motoneurons are unnecessary for ntn1a expression by
the muscle pioneers
We previously proposed that a CaP-derived signal was
responsible for the ability of the muscle pioneers to prevent the
VaP axon from extending farther ventrally [6]. Because Ntn1a is
necessary for the VaP axon to remain stalled at the muscle
pioneers, our previous model raises the possibility that contact with
a CaP/VaP axon is required for the muscle pioneers to express
ntn1a mRNA. To test this possibility, we manually removed CaP/
VaPs prior to axon outgrowth as described in Appel et al. [69].
Contrary to our expectation, ntn1a expression in the muscle
pioneers was not altered by the absence of CaP/VaPs (Figure 10).
This result shows that ntn1a mRNA expression in the muscle
pioneers is independent of CaP/VaP axon contact. However,
localization of Netrin protein is highly regulated [11] and may not
parallel mRNA expression. Thus it remains possible that CaP/
VaP contact alters Ntn1a protein distribution on the muscle
pioneers. Because there are currently no commercially-available
antibodies that recognize zebrafish Ntn1a, and we have not had
success generating antibodies that recognize zebrafish Ntn1a, we
were unable test this hypothesis.
Figure 8. Netrins are unnecessary for CaP axons to extend to
intermediate targets. Projected confocal stacks of GFP-expressing
motor axons in living Tg(mnx1:GFP) embryos injected with various MOs.
A–C. In standard control MO-injected embryos CaP axons extend to the
second intermediate target by 24 hpf (A), the third intermediate target
by 30 hpf (B), and by 36 hpf have extended past the third intermediate
target and wrap around the ventral aspect of the myotome (C). In ntn1a
SBMO (D–F), ntn1b SBMO (G–I), and ntn2 SBMO (J–L) injected embryos
the time course of CaP axon outgrowth was the same as in controls (A–
C). Scale bar =20mm.
doi:10.1371/journal.pone.0025841.g008
Figure 9. Netrins can prevent extension of a second CaP axon
into ventral muscle. Projected confocal stacks of living dye-labeled
motoneurons in embryos injected with various combinations of MOs.
A, D, G, J. Cartoons of a trunk spinal hemisegment detailing ntn1a,
ntn1b, and ntn2 mRNA expression. The red X indicates which netrin
transcript was knocked down in adjacent panels. B–C. ntn1b SBMO-
injected Tg(mnx1:GFP) embryo showing motoneurons (green) and
rhodamine dextran-labeled VaPs (yellow). At 24 (B) and 36 hpf (C) VaP
axons are stopped at muscle pioneers (upper dashed line). E, F, H, I, K,
L. Embryos with individually-labeled CaP and VaP pairs. Dashed ellipses
outline motoneuron cell bodies. In some cases interneurons (*) were
also injected with dye during the labeling procedure. E–F.I nntn2
SBMO-injected embryos the VaP axon (green) stalled at the muscle
pioneers while the CaP axon (red) extended into ventral muscle at
24 hpf (E) and at 36 hpf (F). H–I.I nntn1a plus ntn1b SBMO-injected
embryos two axons extended into ventral muscle at 24 hpf (H), but by
36 hpf (I) one axon retracted to the level of the second intermediate
target (lower dashed line), becoming CaP-like (green). K–L. In the
absence of ntn1a and ntn2 only one axon (green) initially extended to
the third intermediate target (K). However, by 36 hpf a second axon
(red) extended to the third intermediate target, thus both cells become
CaPs (L). Dashed ellipses in L outline the motoneuron cell bodies. Scale
bar =20mm.
doi:10.1371/journal.pone.0025841.g009
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Our data suggest a novel function for intermediate targets in
diversifying a neuronal population. We show that in zebrafish, an
intermediate target-derived signal causes a pair of developmentally
equivalent motoneurons to adopt distinct fates by preventing the
axon of one of them from extending beyond that intermediate
target. During neuronal differentiation, the axons of many neurons
encounter intermediate targets that direct their subsequent
development [31,32,33,34], in many cases by altering gene
expression within the neuron [35,36,37]. Intermediate targets
are well known as locations where axons make pathway choices
that lead to correct circuit formation [32,33,34]. Our results
suggest that at least some intermediate targets may also affect
formation of neuronal circuitry by influencing cell fate specifica-
tion.
CaP and VaP respond differently to intermediate target-
derived Netrins
Our morpholino knockdown experiments suggest that Netrins
are unnecessary for CaP or VaP to extend axons to their targets,
consistent with what has been described from other knockdown
studies of spinal motoneurons in zebrafish and chick and mutant
studies in mouse [18,20,21,38,39,40]. However, after they have
paused at the first intermediate target, VaP axons respond very
differently to Netrin than do CaP axons. One interpretation of this
difference in response to Netrin is that CaP and VaP are
intrinsically different, and thus have distinct fates before their
axons encounter the first intermediate target. An intrinsic
difference in the neurons may be reflected in differences in Netrin
receptor distribution or some yet to be described gene(s). However,
the idea that differential Netrin receptor distribution on CaP and
VaP distinguishes the cells is not supported by data presented here
showing that both CaP and VaP express RNA transcripts for the
same Netrin receptors. Nor is it consistent with expression data of
many other genes, none of which are differentially expressed in
CaP and VaP [41,42,43,44,45,46,47,48]. Moreover, our previous
cell ablation and transplantation experiments showed that
interactions among the axons of the two CaP/VaPs and the
MPs are the crucial step in determining which cell becomes VaP
[6]. Thus, even if CaP and VaP are distinct in some way before
their axons encounter the muscle pioneers, this distinction can be
overridden by interactions among the cells, showing that CaP and
VaP remain developmentally equivalent. These data provide
strong support for the idea that signaling at the muscle pioneers,
rather than intrinsic differences between CaP/VaPs, determines
which cell adopts the VaP fate.
We still do not understand how the two CaP/VaPs respond
differently to Netrin. We previously proposed that the first CaP/
VaP to contact the muscle pioneers invariably becomes CaP [6]. If
this is the case, then Netrin signaling through Dcc in CaP could
promote signaling to the second CaP/VaP, forcing it to become
VaP. We attempted to test this proposal in two ways. We labeled
individual CaP/VaPs with different fluorescent dyes prior to
axogenesis and imaged them continuously as their growth cones
extended toward the muscle pioneers. However, the prolonged
illumination necessary to follow these cells over the relevant time
caused them to die, confirming previous results that demonstrated
labeled cells are very sensitive to photodamage [9]. We also
imaged axons of pairs of CaP/VaPs as they extended to muscle
pioneers in transgenic lines expressing GFP in motoneurons.
However, because the axons are closely apposed, we could not
determine which cell’s axon contacted the muscle pioneers first.
Thus, we were unable to determine whether the first CaP/VaP
that contacts the muscle pioneers invariably becomes CaP.
Although, both cells express the same Netrin receptor mRNAs,
that does not necessarily mean that the receptors act equivalently
in CaP and VaP. Dcc and other Netrin receptors can be modified
posttranslationally and can activate a variety of downstream
effectors that in turn regulate receptor levels at the plasma
membrane [39,49,50,51,52]. Thus we propose that differential
receptor activity underlies differences in the responses of CaP and
VaP to Netrins. Because we do not yet have an indication of how
receptor activity might differ between these two cells, this
hypothesis awaits future testing.
Ntn1a knockdown reveals possible roles for other
intermediate target-derived Netrins
We previously showed that two CaP/VaPs and the muscle
pioneers are required for one of the CaP/VaPs to adopt the VaP
fate. Here we provide evidence that Ntn1a is a muscle pioneer-
derived signal involved in this process. Following knockdown of
Ntn1a, the two CaP/VaPs remain equivalent. Surprisingly, we
also found that following knockdown of Ntn1a, another Netrin,
produced by a more distal intermediate target, can interact with
the axons of the CaP/VaPs to break the equivalence of the two
cells later in their development. Although this particular pair of
motoneurons would not normally interact with intermediate
targets distal to the muscle pioneers, such an interaction may be
important for determining the fates of later-developing zebrafish
motoneurons that also extend axons to the same intermediate
targets [27].
Previous studies have reported motor axon guidance defects in
mutants or following knockdown of potential motor axon guidance
cues expressed by the muscle pioneers or their precursors
[53,54,55]. In each of these cases, ventrally-projecting motoneu-
rons were assayed by labeling with antibodies, thus CaP and VaP
axons, which are closely apposed to one another, could not be
distinguished. Because CaP and VaP were not differentially
Figure 10. A CaP/VaP-derived signal is not required for
expression of the muscle pioneer-derived Netrin signal. This
image shows an 18 hpf embryo from which CaP/VaPs were removed
before axogenesis from the two segments right of the dotted line,
whereas CaP/VaPs were not removed from the segment left of the
dotted line. The zn1 and znp1 antibodies used to label the motoneuron
axons recognize both motoneuron somata and the somata of some
other neurons in the ventral spinal cord [66,71]. The segment on the left
shows a CaP/VaP soma (dot) and its axon (arrow) labeled by the
antibodies. The two segments on the right show somata of other
neurons, but no CaP/VaP somata or motor axons. ntn1a mRNA (blue)
was expressed in the muscle pioneers (*) whether CaP/VaPs were
present (left) or absent (right). Scale bar =20mm.
doi:10.1371/journal.pone.0025841.g010
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of these molecules affects these two motoneurons differentially. It
would be interesting to investigate these guidance cues in more
detail in the future, as it could provide insight into the complex
signaling interactions that may occur at intermediate targets to
specify cell fate.
Do other intermediate targets play a role in breaking
neuronal equivalence?
The type of mechanism we have described here could also be
important for breaking the equivalence between neurons in other
situations. For example, during development of neuromuscular
connectivity in many vertebrates, interactions among motoneu-
rons that belong to a specific motor pool, and fibers within the
muscle these motoneurons innervate, sculpt specific circuits to
refine initially diffuse and redundant synaptic connections [56].
Netrin is expressed in developing muscle in avian embryos [38],
although it is not required for motor axon extension extension
[20,21]. Whether it is required to diversify motoneurons during
formation of specific circuits has not been addressed in avian or
mammalian models. Similarly, neurons within some brain regions
establish topographic maps by making connections with distinct
synaptic partners (reviewed by [32,57]). A common theme in each
of these cases is that neurons that are initially equivalent later
develop distinct synaptic connections. Many mechanisms have
been described that lead to this outcome (reviewed by [32,57]).
However, one mechanism that has not been previously discussed is
that signaling interactions among equivalent neurons and
intermediate targets could break the equivalence between the
neurons, similar to the way that muscle pioneer-derived Ntn1a
breaks the equivalence between two CaP/VaPs. Such a mecha-
nism would ensure that initially equivalent neurons followed
divergent developmental pathways only if they encountered an
appropriate signal from an intermediate target. In the absence of
that signal, the neurons would remain equivalent and able to
follow the same developmental pathway, perhaps making a later
fate decision if an encounter with a more distal intermediate target
broke their equivalence.
The mechanism we describe in this paper suggests a previously
unrecognized role for intermediate targets, not just as guideposts
for directing axon pathway navigation, but also as signaling
centers that affect cell fate. It will be interesting to learn whether
this mechanism is widespread during development.
Materials and Methods
Ethics statement
The protocol for this study was reviewed and approved by the
University of Oregon Institutional Animal Care and Use
Committee (08-21RR).
Animal husbandry and lines
Zebrafish embryos were obtained from natural spawning of
ABC wild types, or parg
mn2Et [42] or Tg(mnx1:GFP)ml2 [58]
transgenic lines. Fish were staged by hours postfertilization at
28.5uC (hpf) [59].
RNA in situ hybridization
RNA in situ hybridization using antisense-digoxigenin labeled
deleted in colorectal carcinoma (dcc, ZFIN ID: ZDB-GENE-011101-2)
[60], neogenin 1 (neo1, ZFIN ID: ZDB-GENE-021031-1) [61],
neogenin 2 (neo2, GenBank Acc: AL907501), and uncoordinated 5b
(unc5b, ZFIN ID: ZDB-GENE-041213-1) [62] oligonucleotide
probes was carried out according to previously described protocols
[63]. Fluorescent in situ hybridization using Down syndrome cell
adhesion molecule (dscam, ZFIN ID: ZDB-GENE-050310-7) [25], islet
2a (isl2a, ZFIN ID: ZDB-GENE-980526-562; a CaP/VaP marker;
[41]), netrin 1a (ntn1a, ZFIN ID: ZDB-GENE-990415-169) [16],
netrin 1b (ntn1b, ZFIN ID: ZDB-GENE-990415-168) [29], netrin 2
(ntn2, ZFIN ID: ZDB-GENE-050310-2) [28], antisense probes was
performed as previously described [64] with the following
modifications [65]: probes against ntn1a mRNA and isl2a mRNA
were made with dinitrophenyl (DNP) labeled nucleotides (Perki-
nElmer Life and Analytical Sciences, Inc., Shelton, CT, USA).
Anti-DNP-HRP conjugated antibody and subsequent develop-
ment with the TSA/Cy5 fluorescent system (PerkinElmer Life and
Analytical Sciences, Inc., Shelton, CT, USA) was used to visualize
mRNA expression.
Immunohistochemistry
The following primary antibodies (Abs) were used: monoclonal
mouse zn-1 [66], monoclonal mouse znp-1 [66], monoclonal
mouse F59 [67], and JL-8 monoclonal mouse anti-GFP (Clontech
Laboratories, Inc., Mountain View, CA, USA). The following
secondary antibodies were used: goat anti-mouse Alexa FluorH
488 (Invitrogen-Molecular Probes; Eugene, OR, USA), goat anti-
mouse Alexa FluorH 633 (Invitrogen-Molecular Probes; Eugene,
OR, USA), and goat anti-mouse-HRP (The Jackson Laboratory,
Bar Harbor, ME, USA).
Motoneuron cell bodies and axons were visualized with
combined antibody labeling using zn1 and znp1, referred to as
zn1/znp1 (1:50/1:1000) [45], or with transgenic lines that express
GFP in motoneurons, Tg(mnx1:GFP)ml2 or parg
mn2Et [47]. Slow
muscle fibers, including muscle pioneers, were visualized by F59
antibody staining (1:10) using the antibody protocol described by
Hutchinson et al. [45]. Anti-GFP antibody staining was used to
visualize GFP expression in embryos that were first taken through
the RNA in situ hybridization (ISH) protocol described above
[63]. Briefly, embryos were fixed after ISH for 1 hour in 4% PFA
in 1x PBS at 4uC, washed for 30 minutes in PBST, and incubated
with primary antibody, JL-8 anti-GFP (1:200). Then embryos were
incubated with either of the following secondary antibodies: goat
anti-mouse-HRP (1:200) or goat anti-mouse Alexa FluorH 633
(1:750), as described in Hutchinson et al. [45]. GFP expressing
cells in embryos incubated with the HRP-conjugated secondary
were visualized by diaminobenzidine (DAB) development as
described in Appel and Eisen [63].
Morpholinos
Morpholino sequences and reverse transcription
PCR. The MOs described in Table 1 were used to knock
down zebrafish Netrins, Dcc, and Dscam or as controls to confirm
MO specificity. All MOs were designed by Gene Tools
(Philomath, OR, USA). Reverse transcription (RT)-PCR was
used to assay wild-type transcript knockdown in embryos injected
with splice-blocking MOs. Table 1 lists primer pairs used to
determine efficacy of MO knockdown. PCR conditions for netrin
transcripts were as described in Suli et al. [26]. Platinum PCR
SuperMix (Invitrogen; Carlsbad, CA, USA) was used to amplify
dscam transcripts. PCR conditions for dscam were as follows: 5 min
94uC; followed by 30 cycles of 94uC, 30 sec/55uC, 30 sec/68uC,
2 min; followed by 5 min 68uC.
Morpholino injections. The following amounts of MO
diluted in 0.2% phenol red solution in water were injected into
1–2 cell stage embryos: standard control MO, 0.5–5.3 ng; ntn1a
SBMO, 2.1–8.9 ng; ntn1b SBMO, 5.6–15 ng; ntn2 SBMO, 5.2–
18 ng; dcc TBMO, 0.5–5.2 ng; dscam SBMO, 4.2–8.4 ng; dscam
TBMO, 4.5–15.3 ng. For double MO injections the same amount
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combination. Injected amounts were calculated by measuring the
diameter of a MO bolus injected into an oil droplet.
Single cell labeling
Individual primary motoneurons were labeled as previously
described [6,68] with the following modification: cells were
injected with a 5% or 2.5% solution of either tetramethylrhoda-
mine-dextran or Alexa FluorH488-dextran (3000 MW, anionic;
Invitrogen-Molecular Probes, Eugene, OR, USA) in 0.2M KCl.
To avoid photodamaging dye-injected cells, they were allowed to
recover for one hour in a dark, 28.5uC incubator before imaging,
were imaged at only three time points over 12 hours, and were
scanned for less than five minutes. Some labeled cells did not
survive. Since previous studies showed that VaP can become CaP
even when CaP is ablated relatively late [6], we only included CaP
and VaP pairs in which both cells survived to 36 hpf, the end point
of our observations.
Motoneuron removal experiments
Motoneurons were removed as previously described [69].
Briefly, embryos were mounted in agar, a small hole dissected in
the skin, and individual motoneurons removed by gentle suction
from a micropipette.
Microscopy
Images of fixed zebrafish embryos were captured on a Zeiss
Axioplan equipped with a digital camera, or on a Zeiss Pascal
confocal microscope. Images of living embryos were captured at
24, 30 and 36 hpf on a Zeiss Pascal confocal microscope using a
40x water immersion objective. The brightness and contrast of
images was adjusted with Zeiss LSM Image Browser (Version
4.2.0.121, Carl Zeiss MicroImaging, Thornwood, NY, USA), or
Photoshop CS4 Extended (Version 11.0, Adobe Systems, Inc., San
Jose, CA, USA).
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